Occupational injuries and toxicant exposures lead to the development of neuroinflammation
by activating distinct mechanistic signaling cascades that ultimately culminate in the …

There is an increasing evidence that inflammation contributes to clinical and functional
outcomes in traumatic brain injury (TBI). Many successful target-engaging, lesion-reducing …

Traumatic brain injury (TBI) is a leading cause of morbidity and mortality. The innate and
adaptive immune responses play an important role in the pathogenesis of TBI. Gamma-delta …

Traumatic brain injury (TBI) is associated with chronic psychiatric complications and
increased risk for development of neurodegenerative pathology. Aged individuals account …

Contemporary microglia morphologies include ramified, activated and amoeboid, with the
morphology of microglia considered highly coupled to the cellular function. Rod microglia …

Traumatic brain injury is common, and often results in debilitating consequences. Even mild
traumatic brain injury leaves approximately 20% of patients with symptoms that persist for …

Cannabidiol (CBD) has numerous pharmacological targets that initiate anti-inflammatory,
antioxidative, and antiepileptic properties. These neuroprotective benefits have generated …

There is accumulating evidence that the circulatory levels of autotaxin (ATX) and
lysophosphatidic acid (LPA) are increased in patients with severe liver disease. However …

Traumatic brain injury (TBI) is a complex, life-threatening condition that causes mortality and
disability worldwide. No effective treatment has been clinically verified to date. Achieving …

Mild traumatic brain injury (mild TBI), often referred to as concussion, is the most common
form of TBI and affects millions of people each year. A history of mild TBI increases the risk of …